© The Author 2008. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
In this month's QJM
| The first 10% of the full text of this article appears below. |
This month's review paper tackles a difficult but important topic: the occurrence of gastrointestinal bleeding (GI) after percutaneous coronary intervention (PCI) or in the words of Foley et al., a deadly combination. GI bleeding is relatively common after PCI (2.3% after primary angioplasty in one study, which also reported a 10% mortality following this complication). The therapeutic dilemma arises from the fact that sudden cessation of anti-platelet therapy following PCI may result in acute stent thrombosis. So, how should the risk of bleeding post-PCI be managed? Following their review of the literature, the authors conclude that those patients considered to be at particular risk